Skip to main content
Transgenic Alfalfa That Accumulates Piceid (Trans-Resveratrol-3-O−β-D-glucopyranoside) Requires the Presence of β -Glucosidase to Inhibit the Formation of Aberrant Crypt Foci in the Colon of CF-1 Mice
Nutrition and Cancer
  • Brian D. Kineman, Iowa State University
  • Angela Au, Iowa State University
  • Nancy L. Paiva, Southeastern Oklahoma State University
  • Mark S. Kaiser, Iowa State University
  • E. Charles Brummer, Iowa State University
  • Diane F. Birt, Iowa State University
Document Type
Publication Version
Accepted Manuscript
Publication Date
Plants have been genetically enhanced to produce a number of products for agricultural, industrial and pharmaceutical purposes. This technology could potentially be applied to providing chemoprevention strategies to the general population. Resveratrol (3,5,4′-trihydroxystilbene) is a compound that has been shown to have protective activity against a number of cancers and could be an ideal candidate for such an application. Alfalfa that was genetically modified to express resveratrol-synthase was used as a model in applying biotechnological approaches to cancer prevention. The transgenic alfalfa, which accumulates resveratrol as a glucoside (piceid = trans-resveratrol-3-O−β-D-glucopyranoside) (152 ± 17.5 μ g piceid/g dry weight), was incorporated into a standard mouse diet at 20% of the diet by weight and fed for 5 wk to 6-wk-old, female CF-1 mice (N = 17–30) that were injected with a single dose of azoxymethane (5 mg/kg body weight). While the addition of resveratrol-aglycone (20 mg/kg diet) to the basal diet reduced the number of aberrant crypt foci/mouse, the transgenic alfalfa did not inhibit the number, size, or multiplicity of aberrant crypt foci in the colon of the CF-1 mice relative to control alfalfa which does not accumulate resveratrol-glucoside. However, diets containing transgenic alfalfa with an exogenous β -glucosidase (860 U/kg diet) did significantly inhibit the number of aberrant crypt foci in the distal 2 cm of the colon of the mice relative to mice fed diets containing the transgenic alfalfa without the enzyme (P < 0.05; Fisher's Combination of p-values). The β -glucosidase alone appeared to have no effect on the inhibition of aberrant crypt foci. These results suggest that piceid in transgenic piceid-accumulating alfalfa was not bioavailable.

This is the accepted manuscript of an article published in Nutrition and Cancer 58 (2007): 66–74, Posted with permission.

Copyright Owner
Lawrence Erlbaum Associates, Inc.
File Format
Citation Information
Brian D. Kineman, Angela Au, Nancy L. Paiva, Mark S. Kaiser, et al.. "Transgenic Alfalfa That Accumulates Piceid (Trans-Resveratrol-3-O−β-D-glucopyranoside) Requires the Presence of β -Glucosidase to Inhibit the Formation of Aberrant Crypt Foci in the Colon of CF-1 Mice" Nutrition and Cancer Vol. 58 Iss. 1 (2007) p. 66 - 74
Available at: